Bi38-3 is a novel CD38/CD3 bispecific T-cell engager with low toxicity for the treatment of multiple myeloma - Fayon, Maxime; Martinez-Cingolani, Carolina; Abecassis, Audrey; Roders, Nathalie; Nelson, Elisabeth; Choisy, Caroline; Talbot, Alexis; Bensussan, Armand; Fermand, Jean-Paul; Arnulf, Bertrand; Bories, Jean-Christophe (Haematologica (Roma), 2021)